Inhibrx Biosciences (INBX) Revenue (2023 - 2025)
Inhibrx Biosciences (INBX) posted quarterly Revenue of $1.3 million for Q2 2025, up 1200.0% year-over-year from $100000.0 in Q2 2024, and up 1200.0% quarter-over-quarter from $100000.0 in Q4 2024.
Inhibrx Biosciences (INBX) Revenue (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has reported Revenue for 3 consecutive years, with $1.3 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Revenue rose 1200.0% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.4 million (down 23.66% YoY), while the FY2025 annual figure was $1.3 million, up 550.0% from the prior year.
- Revenue climbed to $1.3 million in Q2 2025 per INBX's latest filing, from $100000.0 in the prior quarter.
- Across five years, Revenue topped out at $1.6 million in Q4 2023 and bottomed at $30000.0 in Q2 2023.
- Historically, Revenue has averaged $547166.7 across 3 years, with a median of $109500.0 in 2023.
- Annual changes were most pronounced in 2024 — Revenue sank 93.88% — and 2025, when it surged 1200.0%.
- Inhibrx Biosciences' Revenue stood at $1.6 million in 2023, then tumbled by 93.88% to $100000.0 in 2024, then soared by 1200.0% to $1.3 million in 2025.
- Business Quant data shows INBX's Revenue at $1.3 million in Q2 2025, $100000.0 in Q4 2024, and $100000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Inhibrx Biosciences | 1.30 Bn | 1.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.30 Mn |
| Dec 31, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 30,000.00 |